Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION 2025-12-04 09:57
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity 2025-12-04 09:05
Agoda Spotlights Central Asia as Rising Travel Destination for South Korean Travelers 2025-12-04 08:05
POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results 2025-12-04 05:15
Successful Hot Fire Test on a Solid Rocket Motor Thrust Chamber Additively Manufactured by Titomic's TKF™ Cold Spray 2025-12-04 01:55
NYSE Content Advisory: Pre-Market Update + SEC Chair Atkins Encourages IPOs in NYSE Speech 2025-12-03 21:55
U.S. International Trade Commission rules in favor of Infineon in one patent infringement case against Innoscience 2025-12-03 20:05
Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results, Net profit rises 60.1% year-on-year 2025-12-03 19:45
Hyundai Motor, Kia's Robotics LAB and DEEPX Begin Commercialization for Next-Generation On-Device AI Robot Platform 2025-12-03 19:22
Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results 2025-12-03 18:04
Ericsson enters into strategic partnership with LotusFlare to accelerate adoption of network APIs 2025-12-03 17:18
XPOVIO® Approved in Hong Kong for Two Additional Indications in Multiple Myeloma and Diffuse Large B-Cell Lymphoma 2025-12-03 17:00
Otis Wins Silver Award for Outstanding Safety Performance at SBS Transit Safe Business Partner Awards 2025 2025-12-03 13:00
The 110-Year Trans-Pacific Cultural Dialogue: Moutai's Dual Anniversary Brand Celebration Prepares for Grand Opening in the United States 2025-12-03 12:00
Waterdrop Wins 2025 Global Best Case Brands Award, Empowering Inclusive Protection Through Technological Innovation 2025-12-03 11:32
Hyundai Motor Group Unveils Production-Ready Autonomous Mobility Robot Platform 'MobED' at iREX 2025 2025-12-03 09:00
Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR® 2025-12-03 08:43
CNOOC Limited Brings On-stream Weizhou 11-4 Oilfield Adjustment and Satellite Fields Development Project 2025-12-03 08:00
Cboe to Offer Nearly 24-Hour Trading for Russell 2000 Options, Expanding Global Access to U.S. Small-Cap Equities 2025-12-03 07:47
Meet Iris: The only conversational AI intelligence layer built for multi-vendor UC&C observability 2025-12-03 07:45